Chronic urticaria in a child affected by atopic dermatitis: effective treatment with omalizumab

Abstract

This article describes a clinical experience in a 7-year-old girl with chronic spontaneous urticaria and atopic dermatitis, resistant to therapy with antihistamines and topical steroid. Omalizumab treatment not only allowed complete remission of chronic spontaneous urticaria but also significantly improved atopic dermatitis symptoms. The off-label use of omalizumab was well tolerated and no adverse events were reported.

KEYWORDS:

• Chronic urticaria
• atopic dermatitis
• omalizumab

Acknowledgements

Medical writing assistance of this paper was provided by Laura Brogelli, on behalf of Content Ed Net; this assistance was funded by Novartis.

Disclosure statement

The authors report no conflicts of interest.

Additional information

Funding

This supplement was funded by Novartis.